Section-like container element for one or more notes that are not part of the narrative flow (for example, note added in proof, dedication).
Such notes are typically material outside the regular technical content of the document, extra material added by a contributor or by the publisher during or after the regular text has been processed, a note by the editor, or a note added after print publication.
There is no predefined list of types for the @notes-type attribute, but values publishers have used include “added-in-proof”, “dedication”, “conflict-of-interest”, “death-notice”, “editor-note”, “added-post-print”, “added-post-electronic-publication”, and “translator-note”.
A typical end-of-document note is a “Note in Proof”. A Note in Proof contains late-breaking news items or other material produced while the document was being typeset or was otherwise in production, that therefore happened too late to be included in the text of the work. This is typically NOT peer-reviewed content, and citations to other material within such content are usually integrated into the text or put inside the last paragraph, not listed separately in a bibliographic reference list <ref-list>.
The possibility of prepublication online as well as slightly differing content in the online versus print version of the same work has led to an increase in notes that are “only for the print” or “only for web” versions. The @specific-use attribute may be used to mark a note as belonging to only a specific format, such as “print-only”.
<!ELEMENT notes %notes-model; >
(sec-meta?, label?, title?, (address | alternatives | array | boxed-text | chem-struct-wrap | code | fig | fig-group | graphic | media | preformat | supplementary-material | table-wrap | table-wrap-group | disp-formula | disp-formula-group | def-list | list | tex-math | mml:math | p | related-article | related-object | ack | disp-quote | speech | statement | verse-group | x)*, (sec)*, (notes | fn-group | glossary | ref-list)*)
The following, in order:
<abstract>, <ack>, <app>, <back>, <bio>, <boxed-text>, <front>, <journal-meta>, <notes>, <sec>, <trans-abstract>
...
<back>
<glossary>...</glossary>
<notes>
<sec><title>Note Added in Proof</title>
<p>Similar sequence information has been obtained in another study (S. Mishiro,
personal communication) and has been deposited under GenBank accession numbers
–. For the purposes of HBV nomenclature, we have proposed that the
chimpanzee HBV be abbreviated as ChHBV.</p>
</sec>
</notes>
<ref-list>...</ref-list>
...
</back>
...
Boilerplate:
...
<front>
...
<article-meta>...</article-meta>
<notes>
<p content-type="disclaimer"><italic>The information
and/or opinions expressed in this Guest Editorial are
those of the author(s). They are neither endorsed nor
disputed by <roman>Prescribing Physician</roman> or
the Pharma-Physician Coalition. Questions about or
comments on this editorial’s content should be
directed to the corresponding author.</italic></p>
</notes>
</front>
...
Dedication:
...
<front>
...
<article-meta>...</article-meta>
<notes>
<p content-type="dedication">We dedicate this paper
to our professor, Dr. Robert Jemmings, whose critique
of the underlying study identified potential bias in
the analysis and strengthened our argument.</p>
</notes>
</front>
...
Editor’s notes:
...
<front>
...
<article-meta>...</article-meta>
<notes>
<p content-type="editor-note"><sc>EDITOR’S NOTE:</sc>
The study examined in this article was neither blinded nor
placebo-controlled. More recent studies suggest that
traditional medications when compared with placebos do
decrease symptoms of this condition. Further research is
needed to ascertain the efficacy of such medications;
until research is conducted, traditional medications may
be an effectual treatment.</p>
</notes>
</front>
...
Post publication information:
...
<front>
...
<article-meta>...</article-meta>
<notes>
<p content-type="after-epub">After publication, the
authors discovered an error in the text concerning the
administration of the medication levothyroxine. The
text reads: “Individuals prescribed the thyroid
hormone, levothyroxine, should eat within thirty minutes
of taking the medication.” The text should read:
“Individuals prescribed the thyroid hormone,
levothyroxine, should <italic>not</italic> eat within
thirty minutes of taking the medication.”</p>
</notes>
</front>
...
JATS-common1.ent